HROW vs PAHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HROW

59.1
AI Score
VS
HROW Wins

PAHC

38.7
AI Score

Investment Advisor Scores

HROW

59score
Recommendation
HOLD

PAHC

39score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric HROW PAHC Winner
Forward P/E 46.729 13.8313 PAHC
PEG Ratio 0 1.6791 Tie
Revenue Growth 10.9% 4.8% HROW
Earnings Growth -10.3% 24.6% PAHC
Tradestie Score 59.1/100 38.7/100 HROW
Profit Margin -13.5% 6.6% PAHC
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

HROW 1M: -16.5% · 3M: -27.0% PAHC 1M: +16.7% · 3M: +17.0%

Current Technical Phase

HROW

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.5%), weak momentum, RSI 33

RSI (14): 33.4 · Price: $28.07

PAHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 66

RSI (14): 65.6 · Price: $39.81

Fundamentals Snapshot

Metric HROW PAHC
Market Cap — —
Forward P/E 10.2 11.9
Trailing P/E — 16.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin -0.2% 0.1%
EPS -0.99 2.46
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, HROW is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.